Manufacturing, Biologic Drugs

Biocad Announces New Manufacturing Site in North Africa

November 29, 2017

Biocad and Sothema Labs have partnered to release cancer-treating biosimilars into the North African market.

GE Healthcare Completes Acquisition of Bioprocessing Start-Up

November 28, 2017

The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.

FDA Approves Roche’s Hemophilia A Biologic and Expands Indication for Leukemia Drug

November 20, 2017

The agency has approved a biologic-based new molecular entity for treating hemophilia A and has expanded the indication for a leukemia drug to now treat a common form of non-Hodgkin lymphoma.

J&J and Zymeworks in Bispecific Antibody Pact Worth Nearly $1.5 Billion

November 16, 2017

As part of the deal, J&J’s Janssen will pay an upfront payment of $50 million to research, develop, and commercialize up to six bispecific antibodies.

Pall Debuts New Inline Diafiltration Modules for Continuous Bioprocessing

November 16, 2017

The company’s new modules offer scalable single-pass diafiltration and were exclusively showcased during its Leadership Forum series in Westborough, MA.

Improving Sustainability in Pharma Manufacturing

November 15, 2017

Equipment and Processing Report

Optimizing water and HVAC systems can reduce resource use in all pharma facilities, and, for biopharma manufacturing, the supply chain of consumables should be evaluated.

Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.